Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Valdez

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Journal of Nephrology|December 4, 2001
HIV nephropathy and the Duffy antigen/receptor for Chemokines in African AmericansI J Woolley, R Kalayjian, H Valdez, et al.
Blood|June 22, 2001
CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infectionG Chen, P Shankar, C Lange, et al.
Clinical and Diagnostic Laboratory Immunology|May 4, 1999
Levels of proinflammatory cytokines in plasma after pneumoccoccal immunization in human immunodeficiency virus type 1-infected patientsH Valdez, S Purvis, R Asaad, et al.
Archives of Internal Medicine|August 17, 1999
Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcomeH Valdez, M M Lederman, I Woolley, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|May 7, 1999
The utility of clinical and radiographic features in the diagnosis of cytomegalovirus central nervous system disease in AIDS patientsD G Burke, D G Leonard, T F Imperiale, et al.
AIDS Research and Human Retroviruses|August 10, 2000
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials GroupD A Katzenstein, M Hughes, M Albrecht, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapyG R Picchio, H Valdez, R Sabbe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 7, 2021
Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate-to-severe atopic dermatitis: an analysis of patient-reported outcomesM J Cork, A McMichael, J Teng, et al.
Clinical and Experimental Dermatology|May 12, 2018
Association between serum interleukin-17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasisL Fitz, W Zhang, C Soderstrom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999N K Beinker, D L Mayers, C G Lange, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Journal of Nephrology|December 4, 2001
HIV nephropathy and the Duffy antigen/receptor for Chemokines in African AmericansI J Woolley, R Kalayjian, H Valdez, et al.
Blood|June 22, 2001
CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infectionG Chen, P Shankar, C Lange, et al.
Clinical and Diagnostic Laboratory Immunology|May 4, 1999
Levels of proinflammatory cytokines in plasma after pneumoccoccal immunization in human immunodeficiency virus type 1-infected patientsH Valdez, S Purvis, R Asaad, et al.
Archives of Internal Medicine|August 17, 1999
Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcomeH Valdez, M M Lederman, I Woolley, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|May 7, 1999
The utility of clinical and radiographic features in the diagnosis of cytomegalovirus central nervous system disease in AIDS patientsD G Burke, D G Leonard, T F Imperiale, et al.
AIDS Research and Human Retroviruses|August 10, 2000
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials GroupD A Katzenstein, M Hughes, M Albrecht, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapyG R Picchio, H Valdez, R Sabbe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 7, 2021
Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate-to-severe atopic dermatitis: an analysis of patient-reported outcomesM J Cork, A McMichael, J Teng, et al.
Clinical and Experimental Dermatology|May 12, 2018
Association between serum interleukin-17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasisL Fitz, W Zhang, C Soderstrom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999N K Beinker, D L Mayers, C G Lange, et al.
Pageof 9